Ana Berta Sousa

Ana Berta Sousa

Auto-generated profile, based on publicly available information

Ana Berta Sousa

Genetics Service, Unidade Local de Saúde Santa Maria (ULSSM), Centro Académico de Medicina de Lisboa, Lisbon, Portugal

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2010 in The American Journal of Human Genetics
Verified
Journal Article
Closed access
AAAnil K. Agarwal
Anil K. Agarwal
CXChao Xing
Chao Xing
GDGeorge N. DeMartino
George N. DeMartino
DMDario Mizrachi
Dario Mizrachi
MHMaria Dolores Hernandez
Maria Dolores Hernandez
AGAbhimanyu Garg
Abhimanyu Garg

22 November 1999 in Immunogenetics
Verified
Journal Article
Closed access
PDF file
JMJ. Th. Martinsohn
J. Th. Martinsohn
ASA. B. Sousa
A. B. Sousa
LGL. A. Guethlein
L. A. Guethlein
JHJ. C. Howard
J. C. Howard

1 September 2010 in The Journal of Clinical Endocrinology & Metabolism
Verified
Journal Article
Open access
PDF file
AGAbhimanyu Garg
Abhimanyu Garg
MHMaria Dolores Hernandez
Maria Dolores Hernandez
ASAna Berta Sousa
Ana Berta Sousa
LSLalitha Subramanyam
Lalitha Subramanyam
LVLaura E. Martínez de Villarreal
Laura E. Martínez de Villarreal
OBOralia Barboza
Oralia Barboza
Context: Genetic lipodystrophies are rare disorders characterized by partial or complete loss of adipose tissue and predisposition to insulin resistance and its complications such as diabetes mellitus, hypertriglyceridemia, hepatic steatosis, acanthosis nigricans, and polycystic ovarian syndrome. Objective: The objective of the study was to report a novel autosomal recessive lipodystrophy syndrome. Results: We report the detailed phenotype of two males and one female patient, 26–34 yr old, belonging to two pedigrees with an autosomal recessive syndrome presenting with childhood-onset lipodystrophy, muscle atrophy, severe joint contractures, erythematous skin lesions, and microcytic anemia. Other variable clinical features include hypergammaglobulinemia, hepatosplenomegaly, generalized seizures, and basal ganglia calcification. None of the patients had diabetes mellitus or acanthosis nigricans. Two had mild hypertriglyceridemia and all had low levels of high-density lipoprotein cholesterol. Skin biopsy of an erythematous nodular skin lesion from one of the patients revealed evidence of panniculitis. The lipodystrophy initially affected the upper body but later became generalized involving abdomen and lower extremities as well. Conclusions: We conclude that these patients represent a novel autoinflammatory syndrome resulting in joint contractures, muscle atrophy, microcytic anemia, and panniculitis-induced lipodystrophy. The molecular genetic basis of this disorder remains to be elucidated.

1 May 2001 in Molecular Medicine
Verified
Journal Article
Open access
PDF file
RKRalf Küppers
Ralf Küppers
ASAna B. Sousa
Ana B. Sousa
ABAudrey S. Baur
Audrey S. Baur
JSJohn G. Strickler
John G. Strickler
KRKlaus Rajewsky
Klaus Rajewsky
MHMartin-Leo Hansmann
Martin-Leo Hansmann
Classical Hodgkin’s disease (HD) and B-cell non-Hodgkin lymphoma (NHL) occasionally occur in the same patient. Such composite lymphomas represent interesting models to study the pathogenesis of B-cell lymphomas and the relationship between HD and B-cell NHL. We analyzed two composite lymphomas (a combination of classical HD with follicular lymphoma [FL] and a combination of classical HD with B-cell chronic lymphocytic leukemia [B-CLL]) by micromanipulation of single cells from tissue sections and amplification of immunoglobulin V region genes for the clonal relationship of the tumor cells. In both cases, clonally related variable (V) genes with both shared as well as distinct somatic mutations were obtained from the two lymphomas, showing that in each of the cases the distinct tumor cells were members of a common germinal center (GC) B-cell clone. FL cells from two different lymph nodes of patient 1 showed a similar mutation pattern, suggesting that infiltration of these lymph nodes by tumor cells was not restricted to a particular FL cell or subclone. In the FL, a single cell was identified with a mutation signature indicating that premalignant cells can persist in the tissue. The cases presented here further underline the close relationship between HD and B-cell NHL and the role of the GC in lymphomagenesis. Whereas the latter was already suggested for FL and HD, the present study indicates that also in the B-CLL subset characterized by mutated Ig genes, important steps in malignant transformation happen in the GC, and that HRS cells can derive from CD5-positive B cells.

15 March 2011 in American Journal of Medical Genetics Part A
Verified
Journal Article
Closed access
PDF file
KGKaren Gripp
Karen Gripp
EHElizabeth Hopkins
Elizabeth Hopkins
KSKatia Sol-Church
Katia Sol-Church
DSDeborah L. Stabley
Deborah L. Stabley
MAMarni E. Axelrad
Marni E. Axelrad
ALAngela E. Lin
Angela E. Lin

13 February 2023 in PNAS Nexus
Verified
Journal Article
Open access
PDF file
VPVirginie Peter
Virginie Peter
KKKarolina Kaminska
Karolina Kaminska
CSCristina Santos
Cristina Santos
MQMathieu Quinodoz
Mathieu Quinodoz
FCFrancesca Cancellieri
Francesca Cancellieri
CRCarlo Rivolta
Carlo Rivolta
Inherited retinal diseases (IRDs) are a group of ocular conditions characterized by an elevated genetic and clinical heterogeneity. They are transmitted almost invariantly as monogenic traits. However, with more than 280 disease genes identified so far, association of clinical phenotypes with genotypes can be very challenging, and molecular diagnosis is essential for genetic counselling and correct management of the disease. In addition, the prevalence and the assortment of IRD mutations are often population-specific. In this work, we examined 230 families from Portugal, with individuals suffering from a variety of IRD diagnostic classes (270 subjects in total). Overall, we identified 157 unique mutations (34 previously unreported) in 57 distinct genes, with a diagnostic rate of 76%. The IRD mutational landscape was, to some extent, different from those reported in other European populations, including Spanish cohorts. For instance, the EYS gene appeared to be the most frequently mutated, with a prevalence of 10% among all IRD cases. This was, in part, due to the presence of a recurrent, seemingly founder mutation involving the deletion of exons 13 and 14 of this gene. Moreover, our analysis highlighted that as many as 51% of our cases had mutations in a homozygous state. To our knowledge, this is the first study assessing a cross-sectional genotype-phenotype landscape of IRDs in Portugal. Our data reveal a rather unique distribution of mutations, possibly shaped by a small number of rare ancestral events that have now become prevalent alleles in patients.